- Home
- IBRX vs PPBI Comparison
IBRX vs PPBI Comparison
Compare IBRX & PPBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- PPBI
- Stock Information
- Founded
- IBRX 2014
- PPBI 1983
- Country
- IBRX United States
- PPBI United States
- Employees
- IBRX N/A
- PPBI N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- PPBI Major Banks
- Sector
- IBRX Health Care
- PPBI Finance
- Exchange
- IBRX Nasdaq
- PPBI Nasdaq
- Market Cap
- IBRX 2.4B
- PPBI 2.7B
- IPO Year
- IBRX N/A
- PPBI 1997
- Fundamental
- Price
- IBRX $2.81
- PPBI $26.76
- Analyst Decision
- IBRX Buy
- PPBI Buy
- Analyst Count
- IBRX 2
- PPBI 6
- Target Price
- IBRX $17.38
- PPBI $26.50
- AVG Volume (30 Days)
- IBRX 5.6M
- PPBI 456.9K
- Earning Date
- IBRX 11-12-2024
- PPBI 01-27-2025
- Dividend Yield
- IBRX N/A
- PPBI 4.88%
- EPS Growth
- IBRX N/A
- PPBI N/A
- EPS
- IBRX N/A
- PPBI N/A
- Revenue
- IBRX $7,332,000.00
- PPBI $379,785,000.00
- Revenue This Year
- IBRX $2,572.99
- PPBI N/A
- Revenue Next Year
- IBRX $747.59
- PPBI N/A
- P/E Ratio
- IBRX N/A
- PPBI N/A
- Revenue Growth
- IBRX 1218.71
- PPBI N/A
- 52 Week Low
- IBRX $2.82
- PPBI $20.52
- 52 Week High
- IBRX $10.53
- PPBI $30.28
- Technical
- Relative Strength Index (RSI)
- IBRX 29.17
- PPBI 43.91
- Support Level
- IBRX $2.82
- PPBI $26.56
- Resistance Level
- IBRX $3.18
- PPBI $27.63
- Average True Range (ATR)
- IBRX 0.28
- PPBI 0.77
- MACD
- IBRX -0.23
- PPBI -0.21
- Stochastic Oscillator
- IBRX 1.25
- PPBI 9.12
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.
About PPBI Pacific Premier Bancorp Inc
Pacific Premier Bancorp Inc through its subsidiaries, provides banking products and services. It offers cash management, electronic banking services, credit facilities, and retirement accounts, among others.